𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Current Practices in the Management of Chronic Myeloid Leukemia

✍ Scribed by Kantarjian, Hagop M.; Larson, Richard A.; Cortés, Jorge E.; Deering, Kathleen L.; Mauro, Michael J.


Book ID
123421689
Publisher
Elsevier
Year
2013
Tongue
English
Weight
458 KB
Volume
13
Category
Article
ISSN
2152-2650

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Practical management of patients with ch
✍ Francisco Cervantes; Michael Mauro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract Although imatinib has been used as frontline therapy for chronic myeloid leukemia (CML) for nearly a decade, current debate is focused on the incorporation of newer tyrosine kinase inhibitors (TKIs) at diagnosis in light of recent US Food and Drug Administration approval of nilotinib an

Management of Chronic Myeloid Leukemia i
✍ Meinolf Suttorp; Louise Eckardt; Josephine Tabea Tauer; Frederic Millot 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 203 KB

Childhood chronic myelogenous leukemia (CML) is a rare malignancy, and experience with optimal treatment is very limited. Traditionally, allogeneic hematopoietic stem cell transplantation was considered the only curative treatment. Imatinib, a small-molecule inhibitor of the BCR-ABL tyrosine kinase